Supplement company issues urgent recall after finding potentially deadly contamination
The recall includes nearly 1,500 bottles of their Bone & Joint Restore capsules, which were distributed nationwide through major retailers, such as Amazon.
The capsules contain bone marrow and bones from cows, as well as cartilage, per the nutrition label.
The recalled bottles have an expiration label of December 2026 and a lot number of 1224064. Each bottle contains 180 capsules.
Optimal Carnivore first issued the recall in April and has since taken the product off its website.
On Monday, however, the U.S. Food and Drug Administration (FDA) gave it a 'Class 1' label, the most serious designation for products with a high risk of health hazard or death.
As of now, no illnesses have been reported in connection with the affected supplements, however, the company is urging customers with the affected products not to consume the capsules due to the risk of salmonella infection.
The Independent has reached out to the company for comment.
Salmonella bacteria are commonly found in the intestinal tracts of humans and other animals, according to the Mayo Clinic.
Salmonella infection is a common bacterial disease that can affect the intestinal tracts and occurs after drinking contaminated water, eating raw meat, poultry, eggs, or unpasteurized milk.
According to the Cleveland Clinic, Salmonella is the most common form of bacterial food poisoning, with symptoms such as diarrhea, fever, chills, and stomach cramps.
'In some cases, diarrhea can cause severe dehydration and requires prompt medical attention. Life-threatening complications also may develop if the infection spreads beyond the intestines,' Mayo Clinic states.
'The incubation period — the time between exposure and illness — can be 6 hours to 6 days. Often, people who have Salmonella infection think they have the stomach flu,' the clinic explains.
Any individual, adult or infant, with a weakened immune system, is at higher risk of serious illness, according to the Centers for Disease Control and Prevention.
A well-known tomato brand recently issued a voluntary recall due to potential salmonella contamination.
Ray & Mascari Inc. announced the recall of its four packs of Vine Ripe tomatoes on May 2.
The company issued the recall after they were notified by Hanshaw & Caping Farms in Immokalee, Florida, of potential bacterial contamination.
At-risk tomatoes were packaged in plastic cartons with a VINE RIPE TOMATOES label that read "Packed by Ray & Mascari Inc."
The recall extended to several states, including New York, Illinois, Michigan, Pennsylvania, Indiana, Kentucky, Missouri, Mississippi, Tennessee, Ohio, and Wisconsin.
Williams Farms Repack LLC also recalled a crop of tomatoes sold to wholesalers in South Carolina, North Carolina, and Georgia, highlighting the same bacterial risk.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
5 hours ago
- USA Today
'Modern Family' star opens up about heart disorder, getting pacemaker at 29
Julie Bowen is opening up about the heart condition that led her to receive a pacemaker at age 29. In an appearance on the "Inside of You" podcast released on Tuesday, July 1, the "Modern Family" star, 55, discussed being diagnosed with sick sinus syndrome, a heart disorder that caused her to have a low heart rate. Bowen noted she was diagnosed soon after graduating college thanks to her sister, who was in medical school at the time. The actress always had a low heart rate, but when her sister listened to it with a stethoscope, she told Bowen, "You need to go to a cardiologist immediately." Bowen subsequently received her diagnosis and got a pacemaker under her armpit, right after shooting the pilot of her early 2000s NBC series, "Ed." "I was like, 'Oh my God. My life is over. This is so weird. I'm going to die.' I don't know what I thought it was," Bowen said. "I was 29 years old." 'Modern Family' star Julie Bowen clears up that viral hiker rescue story: 'I did nothing' The actress explained the condition would give her a feeling of lightheadedness − as if she had been holding her breath − whenever she was relaxed. Before receiving her pacemaker, which she has had replaced a few times since, doctors warned that this could result in Bowen passing out while behind the wheel of a car and causing an accident. What is sick sinus syndrome? According to the Mayo Clinic, sick sinus syndrome is a kind of heart rhythm disorder that causes heartbeats that are "too fast, too slow, interrupted by long pauses — or an alternating combination of these rhythm issues." The condition is "relatively uncommon." "The risk of developing it increases with age," the clinic notes. "Many people with sick sinus syndrome eventually need an implanted device called a pacemaker to keep the heart in a regular rhythm." 'Modern Family' cast share emotions of last script reading: 'I was sobbing' Bowen previously discussed the condition in a 2011 interview with WebMD. She said at the time that her pacemaker "serves as a monitor for me," adding that she is grateful "to live during a time when the technology exists to treat my condition." She also noted that she doesn't "hear or feel" the device. In fact, when Bowen's pacemaker was brought up on the "Inside of You" podcast, she said, "That's right. I forget about that all the time."
Yahoo
6 hours ago
- Yahoo
Precisio Biotix Therapeutics, Inc. (Precisio) Announces Dosing of a First Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
DOVER, Del., July 03, 2025--(BUSINESS WIRE)--Precisio announced a first-in-man dosing of its staph lysin called ClyO (LYSG101) to a patient with a prosthetic joint infection that had not responded to other treatments. The FDA approved this treatment under a compassionate care IND filed by Mayo Clinic. The patient appears to have tolerated the treatment without any adverse events. It is too early to assess full efficacy, but this is certainly a significant step toward providing additional options to patients, particularly when traditional treatments have failed. Dr. Raymond Schuch, VP, Director of US Operations, notes, "Our sole company focus is the systematic engineering of native lysins and generation of drug-like, optimized and engineered lysins vs. antimicrobial-resistant human pathogens that are associated with high unmet medical needs. Our team possesses unique experience of developing these lysins and transitioning lysins into clinical studies and into patients. To date, our efforts have focused on respiratory, skin, and vaginal infections. We are excited to add prosthetic joint infections to the portfolio of infections we think that we can effectively treat." Mark Engel, Founder and CEO of Precisio said, "We are a platforms plus products company. The key to developing best-in-world lysins is that we use multiple self-developed high-tech proprietary tools. These include tools in bioinformatics, machine-learning, and AI (Zeus™-LysiThru™). We are now at a point where we think we can develop lysin products against many infections including those resistant to standard antibiotics. This patient at Mayo Clinic is the first of what we hope are many examples that we announce in the coming months. Doctors around the globe are anxious to start using our treatments on a compassionate basis since large numbers of patients are not responding to existing treatments." Dr. Assaf Raz, VP of Research and Development noted: "Drug-resistant infections are a pressing global health issue, causing at least 700,000 deaths each year. Without decisive action, this number could rise to 10 million annually by 2050, according to the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance. Our research team is dedicated to developing new lysin therapeutics for large areas of need that bypass antibiotic resistance. We are highly encouraged that our technologies allow us to rapidly create effective solutions for multidrug-resistant pathogens, combating resistant infections and improving patient outcomes." Mr. Engel summarizes that, "The engineered lysins we are developing will have a tremendous impact as additional tool for treating and preventing infections. We think that our lysins will be effective against both gram-positive and gram-negative bacteria. Because we are so efficient in developing them, we will be able to produce our lysins in highly stable formulations with low cost-of-goods, thereby making them available to both developed markets and in the LMIC markets. This presents an opportunity to dramatically change health outcomes around the globe. We are now seeking both strategic and financial support to move forward more rapidly. Our team is highly motivated since we know that every day wasted means lives lost." About Lysins: Lysins are members of a promising new class of antimicrobials - direct lytic agents. Unlike traditional antibiotics, lysins actively hydrolyze the bacterial cell wall, causing extremely rapid lysis and cell death. Due to this unique mechanism of action, lysins are targeted to specific pathogens, can effectively degrade biofilms, and are effective against bacteria resistant to traditional antibiotics. Critically, unlike traditional antibiotics, they do not cause bacterial resistance. About Precisio Biotix Therapeutics Inc. ( Precisio is a US clinical stage biotech company creating lower-cost novel precision engineered biological antibacterials, with an initial focus on respiratory, skin, lung, and prosthetic joint infections. Precisio is a platform-plus-product company (Rx and consumer). The Company has additional R&D operations in India, China, and the UK. Management has had multiple previous successful exits and currently seeks strategic partners for all aspects of the business. Recent news includes (1) a grant award from the Gates Foundation for the development of lysins to treat Bacterial Vaginosis and (2) regulatory approval of a topical Lysin in the EU. View source version on Contacts Aileen Shen, Director of Investor Relations, shencj@ or Daniela Wambold, Corporate Partners, dwambold@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
That cucumber recall? You might want to check your fridge
Does it feel like there have been lots of cucumber recalls lately? You are not wrong. The Food and Drug Administration has classified 137 potential salmonella recall reports for food products containing cucumbers in 2025, more than in any other year with available data. The Centers for Disease Control and Prevention has linked cucumbers to a current salmonella outbreak. Salmonella bacteria are a major cause of foodborne illness, infecting 1.35 million people and killing 420 people each year. Since 2012, the Food and Drug Administration has classified over 3,200 salmonella food reports, according to federal data. On average, a salmonella recall lasts nearly a year, a USA TODAY review of the FDA data found. Currently, there are 217 salmonella recall reports ongoing. You can explore the products here: The FDA has the authority to mandate a recall, but about 99% are voluntarily issued by the companies that make the products. After a recall is initiated, the agency classifies the health hazard presented by the product from Class I (a reasonable probability that the product will cause serious adverse health consequences or death) to Class III (the product is not likely to cause adverse health consequences). About 44% of food recall reports have been classified as Class I. On the other hand, 80% of salmonella food reports are classified as Class I. Most people get infected with salmonella by eating contaminated food like raw or undercooked meat, poultry, eggs, raw or unpasteurized milk and other dairy products, and produce. According to the CDC, 1 in 25 packages of chicken in the grocery store is contaminated with salmonella. Department of Human and Health Services Secretary Robert Kennedy Jr. is among the many promoting raw milk, but experts caution against it. 'We have people whose families have had children and parents and others sickened after drinking raw milk,' said Sandra Eskin, CEO at the nonprofit Stop Foodborne Illness. 'It has salmonella in it, it can have E. coli, and it can have any number of pathogens. That's why they invented pasteurization.' Warmer weather can also create ideal conditions for the bacteria to grow, so it's recommended to refrigerate perishable foods. Other sources of salmonella include contaminated water and the handling of animals. Symptoms start within six hours to six days from the time of exposure and include fever, diarrhea, nausea, vomiting and stomach pain. Most people recover within 4 to 7 days without treatment, but some cases lead to hospitalization and death. Since the start of President Donald Trump's second term, there have been severe cuts and the federal health services workforce is expected to drop from 82,000 to 62,000, USA TODAY previously reported. Trump argued the cuts are a way to save taxpayers' money, but experts say allocating resources towards food safety is critical. An FDA spokesperson told USA TODAY in an email statement that the agency prioritizes food safety and is committed to working with all stakeholders. 'The layoffs relate to administrative staff positions in the FDA. There has been no impact to operational investigators conducting food safety inspections,' the FDA spokesperson said. Over a decade ago, when annual salmonella numbers were estimated to be lower, the U.S. Department of Agriculture estimated that foodborne illness cost the country $3.7 billion per year, most of which was attributed to premature deaths. Eskin, who previously worked at the U.S. Department of Agriculture overseeing food safety and inspections, said recalls are essential for public health. 'A recall is the last line of defense that you and I have to prevent getting sick,' Eskin said, 'if we're going to a restaurant, or more importantly, going to the grocery store.' Dr. Susan Kansagra, chief medical officer at the Association of State and Territorial Health Officials, said in an email statement that federal funds support a wide range of state-level activities related to foodborne illness, like laboratory testing, case reporting, and guiding providers and the public on prevention and treatment. 'Loss of funding and staffing decreases our national capacity to do these activities and therefore quickly detect and respond to foodborne illness,' Kansagra said. This article originally appeared on USA TODAY: After flood of cucumber recalls, you should check your fridge
